Actinium Pharmaceuticals Inc (ATNM)

[demmo47]

The video interview with Dr. Philip Cohen is extremely informative and he explains this complex technology in relatively easily understood laymen’s terms. Thank you for posting this.

http://microcapresearch.com/actinium-pharmaceuticals-antm/

At 9:00 into the video, Dr. Cohen says the process used by Actinium can be used to treat other cancers. At 9:52 the discussion turns to Actinium’s APIT Platform: Products, Process & IP. Dr. Cohen states that Actinium has “managed to link Actinium 225 to a number of different antibodies with specificities to different cancers and that suggests that it is truly a platform with great potential. In theory, any antibody that specifically binds cancer cells could be armed with that payload." Actinium has several patents protecting every part of that process.

The next generation of cancer fighting therapies involves targeted payload cancer therapeutics – the most common agent being the monoclonal antibody. There are a number of companies presently working in that arena and likely more will follow. So not only does Actinium have promising therapies in the pipeline, their process is patented. Other biotechs utilizing the Actinium platform to target and treat other forms of cancer could conceivably owe royalties to Actinium. The revenue streams could be significant.

3DPrintInvestor: your thoughts on this please.